Cargando…

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation

BACKGROUND: We performed a prospective phase II study to compare acute toxicity among five different hypofractionated schedules using proton therapy. This study was an exploratory analysis to investigate the secondary end-point of biochemical failure-free survival (BCFFS) of patients with long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Boram, Cho, Kwan Ho, Lee, Kang Hyun, Joung, Jae Young, Kim, Yeon-Joo, Lee, Sung Uk, Kim, Hyunjung, Suh, Yang-Gun, Moon, Sung Ho, Lim, Young Kyung, Jeong, Jong Hwi, Kim, Haksoo, Park, Weon Seo, Kim, Sun Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327508/ https://www.ncbi.nlm.nih.gov/pubmed/30630500 http://dx.doi.org/10.1186/s13014-019-1210-7

Ejemplares similares

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon
por: Kim, Hyunjung, et al.
Publicado: (2014)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2017)

Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
por: Kim, Nalee, et al.
Publicado: (2023)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
por: Cha, Jihye, et al.
Publicado: (2014)

The Role of Hypofractionation in Proton Therapy
por: Santos, Alexandre, et al.
Publicado: (2022)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
por: Gómez-Aparicio, Maria Antonia, et al.
Publicado: (2021)

Extreme weekly hypofractionation in breast cancer in elderly
por: Blanco Parajón, Sonia, et al.
Publicado: (2020)

Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis
por: Lee, Anbok, et al.
Publicado: (2022)

Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma
por: Thomas, Rehema, et al.
Publicado: (2023)

Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
por: Lee, Sang Min, et al.
Publicado: (2020)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021)

Hypofractionated intensity-modulated radiotherapy in patients with localized prostate cancer: a preliminary study
por: Kang, Hye Jin, et al.
Publicado: (2016)

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma
por: Oh, Dongryul, et al.
Publicado: (2016)

Implementation and utilization of hypofractionation for breast cancer
por: Gilbo, Philip, et al.
Publicado: (2018)

Hypofractionated radiotherapy to treat acne keloidalis nuchae
por: Kwan, Jennifer Yin Yee, et al.
Publicado: (2021)

Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer
por: Lee, Joo Ho, et al.
Publicado: (2013)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Better Care Through Hypofractionation
por: Boisvert-Huneault, Christian, et al.
Publicado: (2022)

Interobserver Variability Prediction of Primary Gross Tumor in a Patient with Non-Small Cell Lung Cancer
por: Cheon, Wonjoong, et al.
Publicado: (2022)

Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients
por: Lee, Byung Min, et al.
Publicado: (2020)

Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial
por: Park, Geumju, et al.
Publicado: (2021)

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer
por: Nakajima, Koichiro, et al.
Publicado: (2022)

Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
por: Kim, Nalee, et al.
Publicado: (2022)

Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma
por: Kim, Young Il, et al.
Publicado: (2012)

Inter‐ and intrafractional dose uncertainty in hypofractionated Gamma Knife radiosurgery
por: Kim, Taeho, et al.
Publicado: (2016)

Beam Angle Optimization for Double-Scattering Proton Delivery Technique Using an Eclipse Application Programming Interface and Convolutional Neural Network
por: Cheon, Wonjoong, et al.
Publicado: (2021)

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer
por: Bayasgalan, Unurjargal, et al.
Publicado: (2021)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2019)

Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray
por: Kim, Sung Han, et al.
Publicado: (2020)

Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
por: Feng, Sen-Quan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f8m2qgb46gdltfu45qffme4c27